healthcar
system
hong
kong
hk
amazingli
effici
among
lowest
number
medic
practition
per
popul
compar
part
world
given
fast
econom
growth
ever
expand
popul
henc
demand
highqual
health
care
need
research
better
medic
care
undoubtedli
intens
provid
nidu
creativ
opportun
research
sever
aspect
pertin
field
respiratori
medicin
prospect
respiratori
research
highlight
despit
fall
rate
tobacco
smoke
lung
cancer
remain
top
cancer
killer
hk
particular
newli
diagnos
nonsmal
lung
cancer
case
driven
target
mutat
oncogen
epiderm
growth
factor
receptor
egfr
anaplast
lymphoma
kinas
alk
molecular
profil
requir
tissu
sampl
increasingli
pivot
allow
person
approach
treatment
help
drive
momentum
advanc
respiratori
diagnost
intervent
pulmonolog
larg
proport
egfrmut
alkrearrang
lung
cancer
make
hk
one
pioneer
clinic
util
cuttingedg
target
therapi
provid
lead
role
mani
landmark
studi
area
investig
mechan
carcinogenesi
altern
genet
express
intracellular
proteom
involv
vitro
mice
xenograft
model
shed
light
potenti
clinic
effect
novel
target
therapi
detect
plasma
egfr
mutat
lung
cancer
impli
wors
prognosi
clinic
studi
outcom
lung
cancer
elderli
therapeut
lymphoepitheliomalik
carcinoma
lelc
peculiar
asian
contribut
knowledg
thu
improv
care
increas
attent
made
earli
detect
lung
cancer
precancer
condit
cancer
prevent
symptom
palliat
also
focu
cancer
research
includ
use
indwel
pleural
cathet
urgent
need
data
inform
optim
approach
malign
pleural
effus
pave
way
research
pleural
diseas
obstruct
sleep
apnoea
osa
underrecogn
diseas
hk
turn
millennium
two
commun
studi
report
preval
rate
osa
men
women
hk
osa
also
found
common
among
children
elderli
occup
driver
diabet
subject
variou
strategi
investig
facilit
diagnosi
osa
includ
craniofaci
featur
questionnair
portabl
sleep
diagnost
decad
effort
uncov
number
cardiovascular
renal
metabol
complic
associ
osa
could
amen
posit
airway
pressur
treatment
mechanist
link
pivot
cardiometabol
consequ
associ
alter
variou
serum
biomark
also
studi
extens
vivo
vitro
importantli
variou
modal
treatment
effect
control
osa
fix
pressur
continu
posit
airway
pressur
cpap
also
investig
compar
strive
better
patient
complianc
outcom
solid
foundat
establish
far
expect
osa
research
continu
prosper
come
decad
lung
function
paramet
investig
provid
appropri
refer
local
adult
chines
establish
local
refer
valu
facilit
robust
research
import
airway
diseas
hk
popul
lung
function
valu
also
contribut
recent
formul
global
lung
initi
gli
equat
lung
function
respirolog
asian
pacif
societi
respirolog
apsr
repres
remark
array
countri
cultur
lung
diseas
profil
asiapacif
region
often
interest
chang
develop
controversi
problem
occur
region
go
unappreciatedand
often
unnoticedbi
other
region
editorsinchief
felt
present
opportun
get
know
region
whilst
provid
entertain
read
alistair
cook
journalist
wrote
regular
letter
bbc
call
letter
america
letter
outlin
event
develop
foibl
problem
opportun
character
era
much
would
write
famili
member
tell
news
day
letter
popular
mani
us
would
inform
entertain
broadcast
year
gone
model
illustr
intent
new
section
respirolog
call
letter
asiapacif
region
invit
author
cover
stimul
topic
current
import
countri
whether
clinic
problem
research
initi
medicalpolit
develop
diseas
trend
simpli
unusu
anecdot
experi
observ
hope
reader
enjoy
letter
look
forward
read
ultim
offer
contribut
help
inform
us
happen
backyard
correspond
opinion
letter
welcom
hk
except
advers
effect
air
pollut
lead
exacerb
patient
chronic
airway
diseas
asthma
focu
mani
collabor
work
inform
clinic
assess
natur
cours
risk
factor
aim
detect
suboptim
asthma
control
earli
intervent
addit
air
pollut
variou
infecti
noninfecti
aetiolog
also
recogn
caus
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
surrog
marker
exhal
breath
condens
copd
correl
diseas
activ
sever
bode
index
composit
index
copd
includ
bodymass
index
airflow
obstruct
dyspnea
exercis
use
predict
mortal
readmiss
role
earli
rehabilit
programm
improv
qualiti
life
aecopd
well
adopt
comprehens
care
programm
would
reduc
hospit
effect
noninvas
ventil
niv
acut
hypercapn
aecopd
continu
home
discharg
wean
strategi
niv
acut
hypercapn
aecopd
investig
thoroughli
noncyst
fibrosi
cf
bronchiectasi
frequent
late
sequela
pulmonari
tuberculosi
tb
domin
microcosm
chronic
suppur
airway
diseas
hk
clinic
effect
inhal
fluticason
lowdos
erythromycin
noncf
bronchiectasi
explor
earli
millennium
earli
late
hk
pioneer
supervis
treatment
approach
tb
well
world
health
organ
advoc
use
direct
observ
treatment
strategi
dot
accredit
tb
laboratori
recognit
center
diseas
control
prevent
cdc
potenti
worldwid
chemotherapi
research
centr
fuell
research
programm
tb
infect
rate
show
clear
downward
trend
last
centuri
nevertheless
slope
level
recent
year
spite
drastic
improv
aspect
manag
tb
still
face
challeng
multidrug
resist
human
immunodefici
viru
infect
widespread
use
immunosuppress
immigr
high
incid
rate
diabet
mellitu
renal
impair
chronic
hepat
b
infect
local
also
put
patient
risk
side
effect
antitubercul
regimen
tb
import
public
health
problem
continu
load
research
effort
resourc
ultim
aim
tb
erad
pain
lesson
epidem
sever
acut
respiratori
syndrom
viru
arous
enthusiasm
research
studi
respiratori
virus
includ
season
influenza
avian
influenza
middl
east
respiratori
syndromerel
coronaviru
mer
cov
respiratori
syncyti
viru
rsv
novel
therapeut
niv
interfac
also
compar
risk
spread
contagi
infect
hospit
environ
effort
improv
prepared
unpredict
attack
viral
epidem
corner
parterr
dilig
garden
work
last
least
thank
three
tightli
knit
local
respiratori
societi
provid
resourc
well
form
import
platform
collabor
centr
